Abstract
Arbutamine, a synthetic catecholamine, coupled with a closed-loop, computerized delivery system was evaluated in conjunction with technetium- 99m sestamibi scintigraphy and echocardiography for the detection of coronary artery disease. Concordance between the imaging methods was 68%, with a similar sensitivity for coronary disease using echocardiography (78%) and technetium-99m sestamibi (76%), although more arbutamine-induced ischemia was noted with perfusion imaging.
Original language | English (US) |
---|---|
Pages (from-to) | 1518-1521 |
Number of pages | 4 |
Journal | American Journal of Cardiology |
Volume | 79 |
Issue number | 11 |
DOIs | |
State | Published - Jun 1 1997 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine